High-throughput quantitative bioluminescence imaging for assessing tumor burden

Methods in Molecular Biology

Volumn 574, Issue , 2009, Pages 37-45

  Contero, Angelina ^a   Richer, Edmond ^a   Gondim, Ana ^a   Mason, Ralph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bioluminescence; charged coupled device cameras (CCD); IGOR Pro; Luciferase; luciferin

Indexed keywords

EID: 84934437186     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-321-3_4     Document Type: Article

References (15)

1. Schaefer, C., Mayer, W. K., Krüger, W., and Vaupel, P. (1993) Microregional distributions of glucose, lactate, ATP and tissue pH in experimental tumours upon local hyperthermia and/or hyperglycaemia. J Cancer Res Clin Oncol 119, 599-608.
2. Lundin, A. (2000) In Bioluminescence and Chemiluminescence, Pt C 305 346-370.
3. Contag, C. H., and Ross, B. D. (2002) It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. JMRI 16, 378-387.
4. Thorne, S. H., and Contag, C. H. (2005) Using in vivo bioluminescence imaging to shed light on cancer biology. Proc IEEE 93, 750-762.
5. Massoud, T. F., and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17, 545-580.
6. Bhaumik, S., and Gambhir, S. S. (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 99, 377-382.
7. Paroo, Z., Bollinger, R. A., Braasch, D. A., Richer, E., Corey, D. R., Antich, P. P., and Mason, R. P. (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3, 117-124.
8. Bollinger, R. A. (2006), Ph.D., UT Southwestern, Dallas.
9. Wang,W., and El-Deiry, W. S. (2003) Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol Ther 2, 196-202.
10. Cecic, I., Chan, D. A., Sutphin, P., Ray, P., Gambhir, S. S., Giaccia, A. J., and Graves, E. E. (2007) Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia. Mol Imaging Biol 6, 219-228.
11. Karam, J. A., Fan, J., Stanfield, J., Richer, E., Benaim, E. A., Frenkel, E., Antich, P., Sagalowsky, A. I., Mason, R. P., and Hsieh, J. -T. (2007) The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-Azacytidine in human bladder cancer therapy. Int J Cancer 120, 1795-1802.
12. Klerk, C. P., Overmeer, R. M., Niers, T. M., Versteeg, H. H., Richel, D. J., Buckle, T., Van Noorden, C. J., and van Tellingen, O. (2007) Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43, 7-13 13.
13. Sarraf-Yazdi, S., Mi, J., Dewhirst, M. W., and Clary, B. M. (2004) Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res 120, 249-255.
14. Kanto, V., Munger, J., and Berry, R. (1994) The CCD Camera Cookbook, Willman-Bell, Inc, Richmond, VA.
15. Dikmen, Z. G., Gellert, G., Dogan, P., Mason, R., Antich, P., Richer, E., Wright, W. E., and Shay, J. E. (2005) A new diagnostic system in cancer research: bioluminescent imaging (BLI). Turk J Med Sci 35, 65-70.